1-4 of 4
Francoise Boyer-Perrard, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

Paola Guglielmelli, MD, Jean-Jacques Kiladjian, MD PhD, Alessandro M. Vannucchi, MD, Ming-hui Duan, MD, Haitao Meng, MD PhD, Ling Pan, MD PhD, Guangsheng He, MD PhD, Srdan Verstovsek, MD PhD, Françoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Dietger Niederwieser, MD PhD, Anna Marina Liberati, MD, Claire Harrison, DM, FRCP, FRCPath, Pantelia Roussou, MSc, Monika Wroclawska, MD, Kevin Majidi, Peter AW te Boekhorst, MD PhD, Heinz Gisslinger, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-137742
Published: 2020
Journal Articles

Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis

Jean-Jacques Kiladjian, MD PhD, Juliette Soret-Dulphy, MD, Matthieu Resche-Rigon, MD PhD, Francoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Valérie Rolland-Neyret, Claude Capron, Sylvie Chevret, MD PhD, Stephane Giraudier, MD PhD, Bruno Cassinat, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 581.
https://doi.org/10.1182/blood-2018-99-110785
Published: 2018
Journal Articles

Long Term Outcome of Patients with MPN-Associated Myelofibrosis Treated with Peg-Interferon-α2a, a French Intergroup of Myeloproliferative Neoplasms (FIM) Study

Jean-Christophe Ianotto, MD, Aurélie Chauveau, MD, Francoise Boyer-Perrard, MD, Emmanuel Gyan, MDPhD, Kamel Laribi, Pascale Cony-Makhoul, MD PhD, Jean-Loup Demory, MD PhD, Benoit De Renzis, MD, Christine Dosquet, MD, Jerome Rey, MD, Lydia Roy, MD, Brigitte Dupriez, MD PhD, Laurent Knoops, MD PhD, Laurence Legros, MD PhD, Mohamed Malou, MD PhD, Pascal Hutin, MD, Dana Ranta, MD, Omar Benbrahim, MD, Valerie Ugo, MD PhD, Eric Lippert, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 323.
https://doi.org/10.1182/blood.V130.Suppl_1.323.323
Published: 2017
Journal Articles

EXPAND: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib in Patients with Myelofibrosis (MF) and Low Platelet Counts (50 × 10 9 /L to 99 × 10 9 /L) at Baseline

Alessandro M. Vannucchi, MD, Heinz Gisslinger, MD, Claire N. Harrison, Haifa Kathrin Al-Ali, MD, Ester Pungolino, MD, Jean-Jacques Kiladjian, MD PhD, Francoise Boyer-Perrard, MD, Franck E. Nicolini, MD PhD, Shuyuan Mo, Edric Atienza, MSHS, Prashanth Gopalakrishna, MBBS, MRCS, Peter A. te Boekhorst
Journal: Blood
Blood (2015) 126 (23): 2817.
https://doi.org/10.1182/blood.V126.23.2817.2817
Published: 2015